AURORA (2009) — Trial Summary

AURORA (2009): Randomized, double-blind, placebo-controlled trial of rosuvastatin 10 mg once daily versus placebo in adults 50–80 years of age undergoing maintenance hemodialysis (NCT00240331). Primary composite: cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke.

References

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.